CYCLOSPORINE (CSP) FOR PROPHYLAXIS AND TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD)

被引：0
|
作者：
DEEG, HJ [1 ]
机构：
[1] FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104
来源：
BLUT | 1984年 / 49卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：242 / 242
页数：1
相关论文
共 50 条
  • [21] New advances in acute graft-versus-host disease prophylaxis
    Davies, JK
    Lowdell, MW
    TRANSFUSION MEDICINE, 2003, 13 (06) : 387 - 397
  • [22] Drug therapy for acute graft-versus-host disease prophylaxis
    Simpson, D
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (03): : 317 - 325
  • [23] PUVA THERAPY FOR ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) OF THE SKIN
    Furlong, T.
    Appelbaum, F. R.
    Carpenter, P. A.
    Deeg, J.
    Doney, K.
    Flowers, M. E. D.
    Kiem, H. -P.
    Martin, P. J.
    Mielcarek, M.
    Nash, R. A.
    Storb, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 137 - 137
  • [24] Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: A prospective, randomized trial
    Deeg, HJ
    Lin, DY
    Leisenring, W
    Boeckh, M
    Anasetti, C
    Appelbaum, FR
    Chauncey, TR
    Doney, K
    Flowers, M
    Martin, P
    Nash, R
    Schoch, G
    Sullivan, KM
    Witherspoon, RP
    Storb, R
    BLOOD, 1997, 89 (10) : 3880 - 3887
  • [25] CYCLOSPORINE-A (CSA) AND PREDNISONE (PRED) PROTOCOL FOR THE PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)
    BULLORSKY, EO
    PUPPO, MI
    SHANLEY, CM
    STEMMELIN, GR
    LOPEZ, M
    CERESETTO, J
    RABINOVICH, O
    BLOOD, 1994, 84 (10) : A705 - A705
  • [26] RISK-FACTORS FOR ACUTE GRAFT-VERSUS-HOST DISEASE ASSOCIATED WITH CYCLOSPORINE AND METHOTREXATE PROPHYLAXIS - RESPONSE
    NASH, RA
    PEPE, MS
    STORB, R
    ANASETTI, C
    APPELBAUM, FR
    DEEG, HJ
    DONEY, K
    MARTIN, PJ
    SULLIVAN, KM
    WITHERSPOON, RP
    BLOOD, 1993, 81 (07) : 1973 - 1974
  • [27] Low Dose Antithymocyte Globulin (ATG) for Graft-Versus-Host Disease (GVHD) Prophylaxis
    Tandra, Anand
    Metheny, Leland
    Yao, David
    Caimi, Paolo F.
    Brister, Lauren
    Cooper, Brenda
    Lazarus, Hillard M.
    Tomlinson, Ben K.
    Malek, Ehsan
    Covut, Fahrettin
    Pinto, Raisa
    deLima, Marcos
    BLOOD, 2016, 128 (22)
  • [28] Phase III study comparing tacrolimus (FK506) with cyclosporine (CSP) for prophylaxis of acute graft-versus-host disease (GVHD) after marrow transplantation from unrelated donors.
    Nash, RA
    Antin, J
    Karanes, C
    Fay, J
    Avalos, B
    Yeager, AM
    Przepiorka, D
    Davies, S
    Petersen, F
    Buell, D
    Fitzsimmons, W
    Bartels, P
    Hansen, J
    Anasetti, C
    Storb, R
    Ratanatharathorn, V
    BLOOD, 1997, 90 (10) : 2499 - 2499
  • [29] Towards a rational graft-versus-host disease (GVHD) prophylaxis: rituximab should not be forgotten
    Van Hoef, Marlies E. H. M.
    HAEMATOLOGICA, 2013, 98 (04) : E40 - E41
  • [30] ACUTE GRAFT-VERSUS-HOST DISEASE - CLINICAL CHARACTERISTICS IN THE CYCLOSPORINE ERA
    VOGELSANG, GB
    HESS, AD
    SANTOS, GW
    MEDICINE, 1988, 67 (03) : 163 - 174
12345